Download Library
Document Type
First in Human Clinical Study of a Novel Dual Mechanism Compound (AR-13324) for the Lowering of IOP in Glaucoma and Ocular Hypertension (Presented at Association for Research in Vision and Ophthalmology, 2013)
Presentations
Discovery and SAR of a Class of Ocularly-active Compounds Displaying a Dual Mechanism of Activity for the Treatment of Glaucoma (Presented at Association for Research in Vision and Ophthalmology, 2012)
Presentations
IOP-lowering efficacy and tolerability of AR-13324, a dual mechanism kinase inhibitor for the treatment of glaucoma (Presented at Association for Research in Vision and Ophthalmology, 2012)
Presentations
Page: FirstPrevious
4
= add file to Briefcase